Letter to the editor - 'Olezarsen, a liver-directed APOC3 ASO therapy for hypertriglyceridemia'

Expert Opin Pharmacother. 2025 Jan;26(1):113. doi: 10.1080/14656566.2024.2432487. Epub 2024 Nov 21.

Author

Melvin Khee Shing Leow^{1

2

3

4}

Affiliations

¹ Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
² Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
³ Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, Singapore, Singapore.
⁴ Department of Endocrinology, Division of Medicine, Tan Tock Seng Hospital, Singapore, Singapore.

PMID: 39562165
DOI: 10.1080/14656566.2024.2432487

No abstract available

Keywords: LDL elevation; Olezarsen; body fat; insulin resistance; thrombocytopenia.